Sachiko Tanaka‐Mizuno

Ipragliflozin, a sodium–glucose cotransporter 2 inhibitor, reduces bodyweight and fat mass, but not muscle mass, in Japanese type 2 diabetes patients treated with insulin: A randomized clinical trial

Hideka Inoue, Katsutaro Morino, Satoshi Ugi et al. · Journal of Diabetes Investigation · 2018 · 59 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Diurnal variation of urinary sodium-to-potassium ratio in free-living Japanese individuals

Toshiyuki Iwahori, Hirotsugu Ueshima, Sayuki Torii et al. · Hypertension Research · 2017 · 45 citations · Full text

Medicine, Nutrition, Physiology +12

Metabolic changes induced by dapagliflozin, an SGLT2 inhibitor, in Japanese patients with type 2 diabetes treated by oral anti-diabetic agents: A randomized, clinical trial

Kayo Horibe, Katsutaro Morino, Itsuko Miyazawa et al. · Diabetes Research and Clinical Practice · 2022 · 26 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Association Between Body Mass Index and All-Cause Death in Japanese Population: Pooled Individual Participant Data Analysis of 13 Cohort Studies

Atsushi Hozawa, Takumi Hirata, Hiroshi Yatsuya et al. · Journal of Epidemiology · 2018 · 24 citations · Full text

Public Health, Health Sciences, Clinical Epidemiology +14

A Combination of Blood Pressure and Total Cholesterol Increases the Lifetime Risk of Coronary Heart Disease Mortality: EPOCH–JAPAN

Michihiro Satoh, Takayoshi Ohkubo, Kei Asayama et al. · Journal of Atherosclerosis and Thrombosis · 2020 · 24 citations · Full text

Public Health, Cardiology, Preventive Medicine +17